Page last updated: 2024-11-05

tripelennamine and Arsenic Encephalopathy

tripelennamine has been researched along with Arsenic Encephalopathy in 1 studies

Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
ABBOZZO, G1

Other Studies

1 other study available for tripelennamine and Arsenic Encephalopathy

ArticleYear
[Action of pyribenzamine in the initial phase of acute arsenic poisoning].
    Bollettino della Societa italiana di biologia sperimentale, 1952, Volume: 28, Issue:4

    Topics: Arsenic; Arsenic Poisoning; Humans; Tripelennamine

1952